CRH reports its next set of results on August 14 with the stock pulling back about 4% over the past month to $100.60, even as options markets show a meaningful uptick in defensive positioning heading into the print.
The clearest signal is in options. The put/call ratio has climbed to 0.91, roughly one standard deviation above its 20-day average of 0.77 — a notable shift higher over the past two weeks. Earlier in July, the PCR ran well below 0.70 as sentiment leaned bullish. The move toward downside protection accelerated into August, suggesting investors are more cautious now than they were heading into the prior quarter. That prior print is worth noting: the stock fell nearly 5% on the day it last reported results at the end of July, with a further 2% slippage over the following week. Short interest and borrow conditions, by contrast, tell a calmer story. At just over 2% of the free float — down nearly 10% over the past month — short positioning has been easing steadily. Borrow availability is exceptionally loose, with shares to lend running at multiples of the current short interest, and the cost to borrow has dropped to 0.27%, its lowest level in months. The lending market offers no signal of squeeze pressure.
The analyst debate centers on how much of CRH's North American infrastructure dominance is already priced in. The bull case rests on the company's position as the largest aggregate and asphalt producer in North America — a business generating 75% of group EBITDA and growing paving revenue at roughly 8% compounded — paired with scope for valuation expansion as capital deployment accelerates. The bear case points to FX headwinds, below-peer margins, and limited near-term visibility on residential and non-residential construction demand. Recent analyst moves have tilted toward caution. Stephens and Truist both trimmed targets following the last print, moving to $125 and $130 respectively, while maintaining positive ratings — a classic "constructive but selective" posture. The consensus mean target of $138.65 implies roughly 38% upside from current levels, though the stock has traded well below that target zone for several months. Jefferies stands out as an outlier, lifting its target to $165.60 in late June on a bullish structural view; the gap between that and the Stephens target illustrates the width of the valuation debate.
Institutional ownership offers some context on the holder base. BlackRock added about 1.75 million shares in the most recent reporting period, bringing its stake to 8.1% of the company. State Street and Boston Partners also added meaningfully. Those are steady, index-linked and value-oriented buyers — the kind of ownership base that absorbs price weakness rather than amplifying it. The ORTEX short score of 32.4 reinforces that short sellers are not making an aggressive directional bet here. Factor rankings are modestly supportive — a strong dividend score of 92nd percentile, a solid EPS surprise rank of 73rd — though momentum remains the soft spot, consistent with the recent underperformance against sector peers. VMC and MLM both gained more than 4% over the past week while CRH added just 2%, a gap that adds to the near-term relative weakness narrative.
The August 14 print will test whether CRH can demonstrate that North American volumes and pricing held up well enough in H1 to justify a re-narrowing of the discount to the analyst consensus — or whether the bear case on margins and demand visibility pushes targets lower still.
See the live data behind this article on ORTEX.
Open CRH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
